Clinical Trial Update: Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the combination of fenofibrate with simvastatin 20 mg versus simvastatin 40 mg monotherapy in hyperlipidemia. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED